Investigating the effectiveness of a smart mental health intervention (inMind) for stress reduction during pharmacological treatment for mild to moderate major depressive disorders: Study protocol for a randomized control trial.
cognitive behavior therapy
cost-effectiveness
major depressive disorders
mindfulness-based intervention
mobile health
randomized controlled trial
relaxation therapy
stress
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2023
2023
Historique:
received:
01
09
2022
accepted:
30
01
2023
medline:
1
4
2023
entrez:
31
3
2023
pubmed:
1
4
2023
Statut:
epublish
Résumé
Although psychological interventions for stress relief, such as cognitive behavioral therapy (CBT) and mindfulness-based stress reduction (MBSR), have been developed, they have not been widely used in treating depression. The use of mobile devices can increase the possibility of actual use by integrating interventions and reducing the difficulty and cost burden of treatment application. This study aims to determine whether "inMind," an integrated mobile application for stress reduction, developed for the general population, decreases stress for patients with mild to moderate major depressive disorder during the pharmacological treatment period. This study is a single-blind, multicenter, randomized, controlled crossover trial. The App, developed in Republic of Korea, provides integrated interventions for stress reduction for the general population through three modules based on mindfulness-based stress reduction, cognitive behavior therapy, and relaxation sounds that are known to be effective in stress reduction ("meditation," "cognitive approach," and "relaxation sounds," respectively). Participants ( The App can potentially be an important addition to depression treatment because of its applicability and the comprehensive nature of the interventions that covers diverse stress-relieving models. https://clinicaltrials.gov/ct2/show/NCT05312203, identifier 2021GR0585.
Sections du résumé
Background
UNASSIGNED
Although psychological interventions for stress relief, such as cognitive behavioral therapy (CBT) and mindfulness-based stress reduction (MBSR), have been developed, they have not been widely used in treating depression. The use of mobile devices can increase the possibility of actual use by integrating interventions and reducing the difficulty and cost burden of treatment application. This study aims to determine whether "inMind," an integrated mobile application for stress reduction, developed for the general population, decreases stress for patients with mild to moderate major depressive disorder during the pharmacological treatment period.
Methods
UNASSIGNED
This study is a single-blind, multicenter, randomized, controlled crossover trial. The App, developed in Republic of Korea, provides integrated interventions for stress reduction for the general population through three modules based on mindfulness-based stress reduction, cognitive behavior therapy, and relaxation sounds that are known to be effective in stress reduction ("meditation," "cognitive approach," and "relaxation sounds," respectively). Participants (
Discussion
UNASSIGNED
The App can potentially be an important addition to depression treatment because of its applicability and the comprehensive nature of the interventions that covers diverse stress-relieving models.
Clinical trial registration
UNASSIGNED
https://clinicaltrials.gov/ct2/show/NCT05312203, identifier 2021GR0585.
Identifiants
pubmed: 36998625
doi: 10.3389/fpsyt.2023.1034246
pmc: PMC10043187
doi:
Banques de données
ClinicalTrials.gov
['NCT05312203']
Types de publication
Journal Article
Langues
eng
Pagination
1034246Informations de copyright
Copyright © 2023 Kim, Shin, Han, Lee, Jeong, Pae, Patkar, Masand and Han.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Clin Psychol Rev. 2018 Feb;59:52-60
pubmed: 29126747
J Affect Disord. 2020 Sep 1;274:733-741
pubmed: 32664009
Br J Soc Clin Psychol. 1967 Dec;6(4):278-96
pubmed: 6080235
J Affect Disord. 2004 Jul;81(1):61-6
pubmed: 15183601
Clin Psychol Sci. 2017;5(6):911-929
pubmed: 29123970
PLoS One. 2018 Jun 20;13(6):e0196645
pubmed: 29924796
J Affect Disord. 2021 Nov 1;294:652-660
pubmed: 34333173
JMIR Ment Health. 2018 Dec 10;5(4):e11290
pubmed: 30530460
Asian Nurs Res (Korean Soc Nurs Sci). 2019 Feb;13(1):30-37
pubmed: 30503903
Int J Med Inform. 2019 Dec;132:103984
pubmed: 31605884
Trials. 2017 May 12;18(1):215
pubmed: 28494802
Int J Ment Health Nurs. 2019 Jun;28(3):635-656
pubmed: 30656813
JAMA Psychiatry. 2021 Mar 1;78(3):261-269
pubmed: 33237285
Ann N Y Acad Sci. 2003 Nov;999:374-6
pubmed: 14681158
Front Psychol. 2018 Jun 21;9:1034
pubmed: 29977221
Bipolar Disord. 2018 Mar;20(2):97-170
pubmed: 29536616
Trials. 2018 Apr 2;19(1):209
pubmed: 29606143
Clin Psychol Sci. 2019 May;7(3):488-501
pubmed: 31263632
BMC Public Health. 2019 Jun 7;19(1):710
pubmed: 31174494
Behav Res Ther. 1995 Mar;33(3):335-43
pubmed: 7726811
J Psychosom Res. 2020 Aug;135:110162
pubmed: 32485622
Compr Psychiatry. 2008 Mar-Apr;49(2):218-23
pubmed: 18243897
Clin Psychol Rev. 2010 Jul;30(5):582-93
pubmed: 20478648
JMIR Mhealth Uhealth. 2020 May 29;8(5):e17458
pubmed: 32348289
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
BMC Psychiatry. 2020 Jan 6;20(1):7
pubmed: 31906903
Trials. 2010 Mar 24;11:32
pubmed: 20334632
Lancet Psychiatry. 2020 Sep;7(9):813-824
pubmed: 32682460
Int J Environ Res Public Health. 2010 Mar;7(3):1036-46
pubmed: 20617017
Span J Psychol. 2015 Jan 13;17:E109
pubmed: 26055051
J Clin Diagn Res. 2016 Jul;10(7):VC01-VC03
pubmed: 27630932
Occup Environ Med. 2016 May;73(5):315-23
pubmed: 26884049
BMC Psychiatry. 2016 Apr 21;16:113
pubmed: 27102812
Psychoneuroendocrinology. 2005 Oct;30(9):846-56
pubmed: 15961250
JAMA. 1999 Apr 14;281(14):1304-9
pubmed: 10208146
Clin Psychol Psychother. 2009 Mar-Apr;16(2):139-47
pubmed: 19229838
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Psychiatry Investig. 2012 Dec;9(4):368-72
pubmed: 23251201
J Med Internet Res. 2021 Dec 22;23(12):e22107
pubmed: 34941541
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Psychiatry Investig. 2018 Mar;15(3):235-245
pubmed: 29486547
Psychol Med. 2016 Mar;46(4):683-97
pubmed: 26620157
Annu Int Conf IEEE Eng Med Biol Soc. 2015;2015:7332-5
pubmed: 26737985
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Neurosci Biobehav Rev. 1995 Summer;19(2):225-33
pubmed: 7630578